Sale!

GCK Gene Hyperinsulinemic Hypoglycemia Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “GCK Gene Hyperinsulinemic Hypoglycemia Type 3 Genetic Test” is a specialized diagnostic procedure designed to identify mutations in the GCK gene, which are associated with Hyperinsulinemic Hypoglycemia Type 3 (HH Type 3). HH Type 3 is a genetic disorder characterized by the excessive production of insulin, leading to recurrent episodes of low blood sugar (hypoglycemia). The GCK gene plays a crucial role in glucose metabolism, and mutations in this gene can disrupt normal insulin secretion, causing the hypoglycemic episodes observed in affected individuals.

This genetic test is a critical tool for confirming the diagnosis of HH Type 3, enabling healthcare providers to tailor treatment plans to manage symptoms effectively and prevent potential complications associated with the condition. Early diagnosis and intervention are key to improving the quality of life for individuals with HH Type 3.

The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the intricate technologies and expertise required to accurately identify mutations in the GCK gene. By opting for this test at DNA Labs UAE, patients and their families can expect reliable results, comprehensive support, and guidance on managing the condition from a team of genetic specialists.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GCK Gene Hyperinsulinemic Hypoglycemia Type 3 Genetic Test

Test Name: GCK Gene Hyperinsulinemic Hypoglycemia Type 3 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GCK Gene Hyperinsulinemic Hypoglycemia Type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinemic Hypoglycemia Type 3.

Test Details

The GCK gene is responsible for providing instructions to make an enzyme called glucokinase. Glucokinase plays a crucial role in regulating glucose levels in the body. Mutations in the GCK gene can lead to a condition called hyperinsulinemic hypoglycemia type 3 (HH3), which is characterized by low blood sugar levels.

NGS stands for next-generation sequencing, which is a high-throughput genetic testing method used to analyze multiple genes simultaneously. In the context of hyperinsulinemic hypoglycemia type 3, an NGS genetic test can be performed to identify mutations in the GCK gene that may be causing the condition.

This genetic test involves collecting a sample of DNA, typically through a blood sample or cheek swab, and then sequencing the DNA to identify any variations or mutations in the GCK gene. The results of the test can help diagnose hyperinsulinemic hypoglycemia type 3 and guide treatment decisions.

It is important to note that genetic testing should be performed by a qualified healthcare professional who can interpret the results and provide appropriate counseling and management options.

Test Name GCK Gene Hyperinsulinemic hypoglycemia type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GCK Gene Hyperinsulinemic hypoglycemia type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinemic hypoglycemia type 3
Test Details

The GCK gene is responsible for providing instructions to make an enzyme called glucokinase. Glucokinase plays a crucial role in regulating glucose levels in the body. Mutations in the GCK gene can lead to a condition called hyperinsulinemic hypoglycemia type 3 (HH3), which is characterized by low blood sugar levels.

NGS stands for next-generation sequencing, which is a high-throughput genetic testing method used to analyze multiple genes simultaneously. In the context of hyperinsulinemic hypoglycemia type 3, an NGS genetic test can be performed to identify mutations in the GCK gene that may be causing the condition.

This genetic test involves collecting a sample of DNA, typically through a blood sample or cheek swab, and then sequencing the DNA to identify any variations or mutations in the GCK gene. The results of the test can help diagnose hyperinsulinemic hypoglycemia type 3 and guide treatment decisions.

It is important to note that genetic testing should be performed by a qualified healthcare professional who can interpret the results and provide appropriate counseling and management options.